Argenx
ARGX
#618
Rank
โ‚น2.735 T
Marketcap
โ‚น44,385
Share price
1.31%
Change (1 day)
1.85%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : โ‚น357.57 B

According to Argenx 's latest financial reports the company has โ‚น357.57 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$โ‚น232.83 B23.29%
2021-12-31$โ‚น188.85 B26.4%
2020-12-31$โ‚น149.40 B58.37%
2019-12-31$โ‚น94.34 B92.24%
2018-12-31$โ‚น49.07 B54.8%
2017-12-31$โ‚น31.70 B565.46%
2016-12-31$โ‚น4.76 B61.14%
2015-12-31$โ‚น2.95 B-36.99%
2014-12-31$โ‚น4.69 B83.34%
2013-12-31$โ‚น2.55 B112.32%
2012-12-31$โ‚น1.20 B-37.12%
2011-12-31$โ‚น1.91 B214.9%
2010-12-31$โ‚น0.60 B